ProductSafer
Findings
Barcode ScannerPopularScan a product barcode instantlyShopping List CheckCheck your weekly shop for concernsIngredient CheckerLook up any ingredient for health flagsExposure TrackerSee which chemicals are in your routineAllergen CheckerFind hidden allergen names on labels
By ConditionFilter findings by health concernHealth GuidesIn-depth plain-English explainersIngredient CheckerSearch or paste a label to check itSafer SwapsCurated alternatives for flagged productsWorst OffendersProducts and brands ranked by riskRecallsLatest FDA and CPSC product recalls
AboutScanSavedDashboard
Subscribe
Subscribe
Findings/Disease & Outbreaks/Liver disease increasingly recognized as major health threat in Europe
🦠[Editorial] Liver health: a neglected aspect of the NCD agenDisease & OutbreaksMedium Concern🔬 Peer-reviewed

Liver disease increasingly recognized as major health threat in Europe

The LancetMay 1, 20262 min read13 views

This is an editorial summary of research originally reported by The Lancet. ProductSafer does not claim ownership of the underlying research. All intellectual property belongs to the original publishers.

Liver disease is the second leading cause of lost work years in Europe, yet it remains overlooked in public health efforts. Experts are calling for new actions from healthcare providers and policymakers to improve how liver health is addressed. Progress has started through efforts like reducing stigma around liver conditions, but much more work remains.

# Editorial Summary

Liver disease represents a significant but often overlooked public health challenge across Europe. According to the European Association for the Study of the Liver, liver conditions rank as the second leading cause of lost working years in Europe, a statistic that reveals just how serious these conditions are for individuals and society. Despite this substantial burden, liver health has largely been neglected in broader discussions about preventing chronic diseases, receiving far less attention than conditions like heart disease, even though the impact on people's lives and livelihoods is comparable.

The EASL-Lancet Liver Commission, published in late 2021, brought this problem into focus by calling for concrete action from healthcare providers and policymakers. The Commission's work has already sparked some positive changes, including efforts to reduce stigma around liver disease through updated terminology and a shift toward earlier detection and intervention. However, these initial steps represent just the beginning of what experts believe needs to be a much larger, coordinated effort to address the full scope of liver health issues in Europe.

The takeaway for consumers is straightforward: pay attention to your liver health, just as you would your heart health. This means being mindful of factors known to harm the liver, such as excessive alcohol consumption, and maintaining a healthy weight to reduce risk of fatty liver disease. If you have concerns about your liver, whether due to family history, lifestyle factors, or existing conditions, talk to your doctor about screening options. Supporting public health initiatives that prioritize liver disease prevention and early detection can also make a difference in shifting how seriously this health threat is taken.

What you can doAI-generated

  • ✓Check whether you're consuming alcohol at levels that could harm your liver—the EASL-Lancet Commission identifies alcohol as a major preventable risk factor—and consider discussing safe drinking limits with your doctor.
  • ✓Ask your healthcare provider about screening for liver disease, particularly if you have risk factors like obesity, hepatitis exposure, or regular alcohol use, since the article emphasizes that earlier detection and intervention can significantly improve outcomes.
  • ✓Review any medications you take regularly with your pharmacist or doctor to understand whether they could affect your liver function, as medication-related liver damage is a preventable risk that deserves attention alongside alcohol and viral hepatitis.

Always consult a healthcare professional for personal medical advice.

Read the full report at the original source

The Lancet

Was this finding useful?

Share this finding

Share:WhatsAppPostShare

Free weekly digest

Findings like this, every week.

We track health and safety research on food, cosmetics, and household products and send you what matters. Join 21 readers.

What would you like to do next?

I use this product

Get the next safety alert before it goes viral

Free weekly digest of health findings about everyday products. No spam, unsubscribe any time.

Advertisement

PreviousTeaching children healthy attitudes toward food and body image
NextFertilizer shortage could raise food prices globally, warns major supplier

More findings in Disease & Outbreaks 🦠

Finerenone: kidney protection beyond type 2 diabetes🦠 Disease & Outbreaks

Finerenone shows kidney protection benefits beyond type 2 diabetes treatment

Finerenone, a drug already used for type 2 diabetes, now shows it can protect kidneys in people with chronic kidney disease who don't have diabetes. This matters because kidney disease kills someone every 20 seconds worldwide, and most patients with non-diabetic kidney disease have limited treatment options. The finding expands who can benefit from this drug and offers new hope for millions of people at risk.

Medium Concern
🔬 Peer-reviewedThe Lancet
5Jun 10, 2026
Ebola outbreak🦠 Disease & Outbreaks

Ebola outbreak in central Africa may be larger than reported

An Ebola outbreak in central Africa is spreading faster than health officials initially thought, with hundreds of suspected cases already reported. The actual number of infections could be significantly higher than current counts suggest, raising concerns about how quickly the virus is moving through the region.

Medium Concern
📰 News reportBBC Health
24May 20, 2026
[Comment] Meningococcal B resurgence in the UK: implications🦠 Disease & Outbreaks

UK sees rise in meningococcal B cases, prompting vaccine strategy review

Meningococcal B disease is spreading again in the UK, putting children and young adults at serious risk. The infection kills 5-15% of people who catch it, even with treatment, and about 1 in 4 survivors face permanent disabilities. Health officials are reconsidering vaccine strategies worldwide to prevent this life-threatening illness.

Medium Concern
🔬 Peer-reviewedThe Lancet
23May 15, 2026

Community discussion

Loading comments…

Join the discussion

Comments are reviewed before appearing publicly.

0/1000
Back to all findings

Key facts

Product[Editorial] Liver health: a neglected aspect of the NCD agen
CategoryDisease & Outbreaks
SeverityMedium Concern
SourceThe Lancet
PublishedMay 1, 2026
Reading2 min read

Jump to

What to doOriginal sourceComments

Share

Share:WhatsAppPostShare

Never miss a finding

Get the latest health findings delivered to your inbox. Only the important stuff. No spam.

We'll send a confirmation email. Unsubscribe anytime.

Support ProductSafer on Ko-fi

About·Privacy·Terms·Disclosure·Advertise·RSS Feed

© 2026 ProductSafer. All summaries credit and link to their original published sources.

ProductSafer publishes editorial summaries of third-party health research and news. Content is for informational purposes only and does not constitute medical advice.